Federal health researchers and vaccine maker Novavax announced Monday that they will begin a Phase 3 trial for Novavax’s COVID-19 vaccine candidate in the United States, marking the fifth such shot i… [+3608 chars]
COVID-19 vaccine from Novavax is latest to enter Phase 3 trial in U.S. – CBS News
